Cancer Family
Lymphocytic Neoplasm
CI-CAN-00000223Explore in graph →
HematologicNon-malignant3,036 active trials72 approved drugs345 evidence items
- NCIt
- C7065
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000223Explore in graph →
Clinical trials
12,949 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02721407 | Anti-CD22 CAR-T Therapy for CD19-refractory or Resistant Lymphoma Patients(MendCART) | unknown | Phase 1 | 20 | Xinqiao Hospital of ChongqingOTHER | 1 | Mar 10, 2017 | clinicaltrials |
| NCT00209209 | Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCL(MCLelderly) | unknown | Phase 3 | 570 | European Mantle Cell Lymphoma NetworkOTHER | 7 |
| Mar 7, 2017 |
| clinicaltrials |
| NCT01449344 | Efficacy and Safety of R-HAD Alone or in Combination With Bortezomib in Patients With Relapsed or Refractory MCL((R-HAD)) | unknown | Phase 3 | 128 | Prof. Dr. M. Dreyling (co-chairman)OTHER | 2 | Mar 7, 2017 | clinicaltrials |
| NCT03054532 | Phase II Study of Durvalumab in Combination With Lenalidomide in Relapsed/Refractory NK-T-cell Lymphoma | unknown | Phase 2 | 22 | Singapore General HospitalOTHER | 1 | Feb 16, 2017 | clinicaltrials |
| NCT02087657 | Pilot Study Exploring the Use of Hyperbaric Oxygen in Autologous Peripheral Blood Stem Cell Transplantation(Auto-HBO) | unknown | N/A | 20 | University of Kansas Medical CenterOTHER | 1 | Feb 14, 2017 | clinicaltrials |
| NCT02955628 | RICE-ibrutinib in Relapsed DLBCL | unknown | Phase 2 | 34 | Singapore General HospitalOTHER | 1 | Feb 14, 2017 | clinicaltrials |
| NCT03051542 | Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Natural Killer/T-cell Lymphoma | unknown | N/A | 60 | Peking University Cancer Hospital & InstituteOTHER | 1 | Feb 13, 2017 | clinicaltrials |
| NCT03051555 | 18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Natural Killer/T-cell Lymphoma | unknown | N/A | 60 | Peking University Cancer Hospital & InstituteOTHER | 1 | Feb 13, 2017 | clinicaltrials |
| NCT03051568 | Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Peripheral T-cell Lymphoma | unknown | N/A | 80 | Peking University Cancer Hospital & InstituteOTHER | 1 | Feb 13, 2017 | clinicaltrials |
| NCT03051581 | 18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Peripheral T-cell Lymphoma | unknown | N/A | 80 | Peking University Cancer Hospital & InstituteOTHER | 1 | Feb 13, 2017 | clinicaltrials |
| NCT02519114 | Haploidentical Bone Marrow Stem Cell Transplantation in Patients With Multiple Myeloma | unknown | Phase 1 / Phase 2 | 24 | Maastricht University Medical CenterOTHER | 1 | Feb 10, 2017 | clinicaltrials |
| NCT02572596 | Comparing Intermediate-dose CTX+ G-CSF Plus or Not rhTPO for PB CD34+ Cells Mobilization in MM Patients | unknown | N/A | 200 | Wang GuorongOTHER | 1 | Feb 9, 2017 | clinicaltrials |
| NCT02916459 | EBUS-TBNA vs Flex 19G EBUS-TBNA | unknown | N/A | 250 | Heidelberg UniversityOTHER | 1 | Feb 7, 2017 | clinicaltrials |
| NCT03035344 | Study of the Intermediate Metabolism in Children With Acute Lymphoblastic Leukemia (ALL) | unknown | — | 25 | Aristotle University Of ThessalonikiOTHER | 1 | Jan 30, 2017 | clinicaltrials |
| NCT02474550 | Multicenter Prospective Registry Study of Diffuse Large B Cell Lymphoma | unknown | — | 1,000 | Ajou University School of MedicineOTHER | 1 | Jan 26, 2017 | clinicaltrials |
| NCT03027739 | CART-19 Cells For MRD Positive CD19+ ALL(CCFMPCA) | unknown | Phase 2 / Phase 3 | 20 | Fujian Medical UniversityOTHER | 1 | Jan 23, 2017 | clinicaltrials |
| NCT03023358 | Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma Patients | unknown | Phase 3 | 174 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Jan 18, 2017 | clinicaltrials |
| NCT03022123 | The Study of Pegylated Liposomal Doxorubicin Contrast Epirubicin for the Treatment of Diffuse Large B-cell Lymphoma | unknown | N/A | 270 | Hebei Medical University Fourth HospitalOTHER | 1 | Jan 16, 2017 | clinicaltrials |
| NCT03022747 | Optimizing 6-mercaptopurine Therapy in Pediatric Acute Lymphoblastic Leukemia by Using Allopurinol | unknown | Phase 2 | 60 | Vastra Gotaland RegionOTHER_GOV | 2 | Jan 16, 2017 | clinicaltrials |
| NCT03016988 | The Efficacy and Safety of Bortezomib Combined With Fludarabine and Cytarabine Treatment for Mantle Cell Lymphoma | unknown | Phase 2 | 50 | Tingbo LiuOTHER | 0 | Jan 11, 2017 | clinicaltrials |
| NCT03010579 | Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation | unknown | Phase 4 | 70 | Peking UniversityOTHER | 1 | Jan 5, 2017 | clinicaltrials |
| NCT02585947 | To Compare the Efficacy of a Prophylactic Use of Tenofovir by Duration for the Non-Hodgkin's Lymphoma | unknown | Phase 4 | 90 | Seoul National University HospitalOTHER | 1 | Dec 21, 2016 | clinicaltrials |
| NCT02996617 | PEG-rhG-CSF in Patients With Non-Hodgkin Lymphoma Receiving Chemotherapy to Prevent Neutropenia | unknown | Phase 4 | 240 | Shandong Provincial HospitalOTHER_GOV | 1 | Dec 19, 2016 | clinicaltrials |
| NCT02981199 | Microtransplantation Versus Auto-SCT in ≥PR Multiple Myeloma Patients | unknown | N/A | 80 | Chen WenmingOTHER | 1 | Dec 16, 2016 | clinicaltrials |
| NCT02992834 | Anti-CD19:TCRζ Chimeric Antigen Receptor-T Cells in the Treatment for CD19+ B Cell Lymphoma | unknown | Phase 4 | 10 | jiangjingtingOTHER | 1 | Dec 14, 2016 | clinicaltrials |
| NCT02987127 | Prospective Study of Frontline H Pylori Eradication in the Treatment of Early-stage Extragastric MALT Lymphoma | unknown | — | 21 | National Taiwan University HospitalOTHER | 1 | Dec 8, 2016 | clinicaltrials |
| NCT02987244 | Chidamide Plus CHOEP Combined With Upfront ASCT in Untreated Peripheral T-cell Lymphoma | unknown | Phase 1 / Phase 2 | 100 | Peking Union Medical College HospitalOTHER | 1 | Dec 8, 2016 | clinicaltrials |
| NCT02742727 | CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma | unknown | Phase 1 / Phase 2 | 10 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Dec 6, 2016 | clinicaltrials |
| NCT02892695 | PCAR-119 Bridge Immunotherapy Prior to Stem Cell Transplant in Treating Patients With CD19 Positive Leukemia and Lymphoma | unknown | Phase 1 / Phase 2 | 10 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Dec 6, 2016 | clinicaltrials |
| NCT02983942 | Ketogenic Diet Adjunctive to HD-MTX Chemotherapy for Primary Central Nervous System Lymphoma | unknown | Phase 1 / Phase 2 | 50 | Beijing Tiantan HospitalOTHER | 1 | Dec 6, 2016 | clinicaltrials |
| NCT02968472 | A Phase I Trial of 4SCAR19 Cells in the Treatment of Relapsed and Refractory B Cell Leukemia | unknown | Phase 1 | 30 | The First People's Hospital of YunnanOTHER | 1 | Nov 18, 2016 | clinicaltrials |
| NCT02965157 | Pilot Study of Anti-CD20-CAR-engineered T Cells in Patients With Chemotherapy Resistant or Refractory CD20+ Lymphoma | unknown | Phase 1 / Phase 2 | 15 | Beijing Biohealthcare Biotechnology Co.,LtdINDUSTRY | 1 | Nov 16, 2016 | clinicaltrials |
| NCT02961296 | Helicobacter Pylori Antibiotic Susceptibility Testing of Korea | unknown | — | 400 | Asan Medical CenterOTHER | 1 | Nov 10, 2016 | clinicaltrials |
| NCT00931229 | Incidence of Hepatitis B Reactivation in Non-Hodgkin's Lymphoma Patients | unknown | N/A | 202 | National Health Research Institutes, TaiwanOTHER | 1 | Nov 9, 2016 | clinicaltrials |
| NCT02916420 | Efficacy and Safety of Pomalidomide in Combination With Low-dose Dexamethasone in Chinese Patients With Relapsed and Refractory Multiple Myeloma | unknown | Phase 3 | 73 | Jiangsu Simcere Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 2, 2016 | clinicaltrials |
| NCT01653067 | STORM: Temsirolimus, Rituximab and DHAP for Relapsed and Refractory Diffuse Large B-cell Lymphoma(STORM) | unknown | Phase 2 | 88 | Mathias Witzens-HarigOTHER | 1 | Oct 27, 2016 | clinicaltrials |
| NCT02944812 | Chidamide for Refractory/Relapsed Peripheral T Cell Lymphoma | unknown | Phase 2 | 12 | Guangdong Provincial People's HospitalOTHER | 1 | Oct 26, 2016 | clinicaltrials |
| NCT02819583 | CAR-T Cell Immunotherapy in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma | unknown | Phase 1 / Phase 2 | 10 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Oct 25, 2016 | clinicaltrials |
| NCT02938741 | ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors | unknown | Phase 4 | 130 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Oct 25, 2016 | clinicaltrials |
| NCT02213861 | Efficacy, Safety and Tolerability Study of SHAPE in IA, IB or IIA Cutaneous T-cell Lymphoma | unknown | Phase 2 | 60 | TetraLogic PharmaceuticalsINDUSTRY | 1 | Oct 20, 2016 | clinicaltrials |
| NCT02935348 | Whole Body PET-MRI in Paediatric and Adolescent Lymphoma(PET/MRI) | unknown | — | 25 | University College, LondonOTHER | 1 | Oct 17, 2016 | clinicaltrials |
| NCT02810223 | Efficacy of CART-19 Cell Therapy in B Cell Acute Lymphoblastic Leukemia | unknown | Phase 1 | 20 | Beijing Sanwater Biological Technology Co., Ltd.INDUSTRY | 1 | Oct 14, 2016 | clinicaltrials |
| NCT02933775 | CD19-redirected Autologous Cells (CAR-CD19 T Cells) | unknown | Phase 1 | 45 | RenJi HospitalOTHER | 1 | Oct 14, 2016 | clinicaltrials |
| NCT02934204 | Temozolomide in Treatment of Patients With Primary Central Nervous System Lymphoma | unknown | Phase 2 | 51 | Guangdong Provincial People's HospitalOTHER | 1 | Oct 14, 2016 | clinicaltrials |
| NCT02929615 | Study of Standard and Individualized Treatment Model for Relapse and Refractory Lymphatic System Malignant Tumors | unknown | Phase 4 | 50 | Peking UniversityOTHER | 1 | Oct 12, 2016 | clinicaltrials |
| NCT02931201 | Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Diffuse Large B-cell Lymphoma | unknown | N/A | 100 | Peking University Cancer Hospital & InstituteOTHER | 1 | Oct 12, 2016 | clinicaltrials |
| NCT02928861 | 18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Diffuse Large B-cell Lymphoma | unknown | N/A | 100 | Peking University Cancer Hospital & InstituteOTHER | 1 | Oct 10, 2016 | clinicaltrials |
| NCT02927717 | An Italian Experience on Grade 3b Follicular Lymphoma(FL3b-Oss-2015) | unknown | — | 60 | A.O.U. Città della Salute e della ScienzaOTHER | 0 | Oct 7, 2016 | clinicaltrials |
| NCT02894645 | Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study | unknown | Phase 4 | 500 | National University Hospital, SingaporeOTHER | 2 | Sep 30, 2016 | clinicaltrials |
| NCT02905916 | The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy | unknown | Phase 4 | 217 | Peking UniversityOTHER | 1 | Sep 19, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Mar 10, 2017source: clinicaltrials